PRIMARY STUDY
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats
Key Findings: THCV may have therapeutic potential in reducing nausea.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): Canada
Year of Pub: 2013
Cannabinoids Studied: Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV)
Phytocannabinoid Source: Unspecified
Citation: Rock EM, et al. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. Br J Pharmacol. 2013; 170:671-8. doi: 10.1111/bph.12322
Authors: Rock EM, Sticht MA, Duncan M, Stott C, Parker LA
